Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM)
Judith Trotman, Katherine Rankin, Ibrahim Tohidi‐Esfahani, Alessandra Tedeschi, Constantine S. Tam, Christian Buske, Roger G. Owen, Véronique Leblond, Meletios A Dimopoulos, Philip M. Smallwood, Heather Allewelt, Wai‐Yee Chan, Radha Prathikanti, Jingjing Schneider, Remus Vezan, Stephen Opat (2024). Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM). , 144(Supplement 1), DOI: https://doi.org/10.1182/blood-2024-200334.
Article43 days agoBiomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia
Constantine S. Tam, Stephen Opat, Shirley D’Sa, Wojciech Jurczak, Hui‐Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón García‐Sánz, Helen O. McCarthy, Stephen P. Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward N. Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C. Minnema, Christian Buske, Véronique Leblond, Steven P. Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai‐Yee Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios A Dimopoulos (2024). Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia. , 8(7), DOI: https://doi.org/10.1182/bloodadvances.2023010906.
Article43 days agoLong-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM)
Judith Trotman, Katherine Rankin, Ibrahim Tohidi‐Esfahani, Alessandra Tedeschi, Constantine S. Tam, Christian Buske, Roger G. Owen, Véronique Leblond, Meletios A Dimopoulos, Philip M. Smallwood, Heather Allewelt, Wai‐Yee Chan, Radha Prathikanti, Jingjing Schneider, Remus Vezan, Stephen Opat (2024). Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM). , 144(Supplement 1), DOI: https://doi.org/10.1182/blood-2024-200334.
Article43 days agoBortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
Christian Buske, Meletios A Dimopoulos, Alexander Grunenberg, Efstathios Kastritis, Cécile Tomowiak, Beatrice Mahé, Xavier Troussard, Roman Hájek, Andreas Viardot, Olivier Tournilhac, Thérèse Aurran, Stéphane Leprêtre, Hacène Zerazhi, Bénédicte Hivert, Véronique Leblond, Sophie de Guibert, Lena Brandefors, Ramón García‐Sánz, María Gomes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Jens Dreyhaupt, Rainer Muche, Pierre Morel (2023). Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia. , 41(14), DOI: https://doi.org/10.1200/jco.22.01805.
Article43 days agoReport of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients
Christian Buske, Jorge J. Castillo, Jithma P. Abeykoon, Ranjana H. Advani, Suzanne O. Arulogun, Andrew R. Branagan, Xinxin Cao, Shirley D’Sa, Jian Hou, Prashant Kapoor, Efstathios Kastritis, Marie José Kersten, Véronique Leblond, Merav Leiba, Jeffrey Matous, Jonas Paludo, Lugui Qiu, Constantine S. Tam, Alessandra Tedeschi, Sheeba K. Thomas, Ibrahim Tohidi‐Esfahani, Marzia Varettoni, Josephine M. I. Vos, Ramón García‐Sánz, Jesús F. San Miguel, Meletios A Dimopoulos, Steven P. Treon, Judith Trotman (2023). Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients. , 60(2), DOI: https://doi.org/10.1053/j.seminhematol.2023.03.005.
Article43 days ago